Philip J Perry

829 total citations
14 papers, 720 citations indexed

About

Philip J Perry is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Philip J Perry has authored 14 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Physiology. Recurrent topics in Philip J Perry's work include Advanced biosensing and bioanalysis techniques (8 papers), DNA and Nucleic Acid Chemistry (6 papers) and RNA Interference and Gene Delivery (6 papers). Philip J Perry is often cited by papers focused on Advanced biosensing and bioanalysis techniques (8 papers), DNA and Nucleic Acid Chemistry (6 papers) and RNA Interference and Gene Delivery (6 papers). Philip J Perry collaborates with scholars based in United Kingdom. Philip J Perry's co-authors include Lloyd R. Kèlland, Anthony P. Reszka, Stephen Neidle, Sharon Gowan, Terence C. Jenkins, Martin A. Read, Paolo Polucci, John O. Trent, John A. Hadfield and John R. P. Arnold and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Current Pharmaceutical Design.

In The Last Decade

Philip J Perry

14 papers receiving 706 citations

Peers

Philip J Perry
Paolo Polucci Italy
Hollis S. Kezar United States
Shende Jiang China
Mauro Marzi Italy
Vincent J. Colandrea United States
Arlene Dietrich United States
Kent Neuenschwander United States
Lucille A. Cosby United States
Hiroyuki Sugumi Japan
Alan M. Birch United Kingdom
Paolo Polucci Italy
Philip J Perry
Citations per year, relative to Philip J Perry Philip J Perry (= 1×) peers Paolo Polucci

Countries citing papers authored by Philip J Perry

Since Specialization
Citations

This map shows the geographic impact of Philip J Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J Perry more than expected).

Fields of papers citing papers by Philip J Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J Perry. The network helps show where Philip J Perry may publish in the future.

Co-authorship network of co-authors of Philip J Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J Perry. A scholar is included among the top collaborators of Philip J Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J Perry. Philip J Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Harrington, Dean J., Eduardo Cemeli, Siân Estdale, et al.. (2003). Genotoxicity studies on DNA-interactive telomerase inhibitors with application as anti-cancer agents. Teratogenesis Carcinogenesis and Mutagenesis. 23(S2). 31–41. 3 indexed citations
2.
Cairns, Donald, Rosaleen J. Anderson, Philip J Perry, & Terence C. Jenkins. (2002). Design of Telomerase Inhibitors for the Treatment of Cancer. Current Pharmaceutical Design. 8(27). 2491–2504. 17 indexed citations
3.
Perry, Philip J, et al.. (2001). Telomerase inhibitors for the treatment of cancer: the current perspective. Expert Opinion on Investigational Drugs. 10(12). 2141–2156. 31 indexed citations
4.
Perry, Philip J & Terence C. Jenkins. (2001). DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition. Mini-Reviews in Medicinal Chemistry. 1(1). 31–41. 39 indexed citations
5.
Perry, Philip J, et al.. (1999). Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines. Anti-Cancer Drugs. 10(6). 591–596. 31 indexed citations
6.
Perry, Philip J, et al.. (1999). Recent advances in the development of telomerase inhibitors for the treatment of cancer. Expert Opinion on Investigational Drugs. 8(12). 1981–2008. 37 indexed citations
7.
Perry, Philip J, Martin A. Read, Sharon Gowan, et al.. (1999). 2,7-Disubstituted Amidofluorenone Derivatives as Inhibitors of Human Telomerase. Journal of Medicinal Chemistry. 42(14). 2679–2684. 206 indexed citations
8.
Perry, Philip J, Anthony P. Reszka, Martin A. Read, et al.. (1998). Human Telomerase Inhibition by Regioisomeric Disubstituted Amidoanthracene-9,10-diones. Journal of Medicinal Chemistry. 41(24). 4873–4884. 144 indexed citations
9.
Perry, Philip J, Sharon Gowan, Anthony P. Reszka, et al.. (1998). 1,4- and 2,6-Disubstituted Amidoanthracene-9,10-dione Derivatives as Inhibitors of Human Telomerase. Journal of Medicinal Chemistry. 41(17). 3253–3260. 138 indexed citations
10.
Perry, Philip J & Lloyd R. Kèlland. (1998). Telomeres and telomerase: targets for cancer chemotherapy?. Expert Opinion on Therapeutic Patents. 8(12). 1567–1586. 24 indexed citations
11.
Perry, Philip J, et al.. (1997). Synthesis of cytotoxic furonaphthoquinones: Regiospecific synthesis of diodantunezone and 2-ethylfuronaphthoquinones. Tetrahedron. 53(9). 3195–3204. 19 indexed citations
12.
Perry, Philip J, et al.. (1996). The Rapid Reduction of α,α-Diaryl Alcohols To The Corresponding Alkanes Using lodotrimethylsilane. Synthetic Communications. 26(1). 101–111. 11 indexed citations
13.
Perry, Philip J, et al.. (1996). The Regiospecific C-3 Lithiation of 5-Ethyl-2-furoic acid: An Approach to Key Natural Product Intermediates. Applied Organometallic Chemistry. 10(5). 389–392. 3 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Polucci Breakdown of academic impact, for papers by Hollis S. Kezar Breakdown of academic impact, for papers by Shende Jiang Breakdown of academic impact, for papers by Mauro Marzi Breakdown of academic impact, for papers by Vincent J. Colandrea Breakdown of academic impact, for papers by Arlene Dietrich Breakdown of academic impact, for papers by Kent Neuenschwander Breakdown of academic impact, for papers by Lucille A. Cosby Breakdown of academic impact, for papers by Hiroyuki Sugumi Breakdown of academic impact, for papers by Alan M. Birch
Rankless by CCL
2026